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Abstract
The  aim  of  our  work  was  to  assess  long-term  results  of  autologous  peripheral  blood
hematopoietic  stem cell  application in patients with peripheral  arterial  diseases.  Peripheral
blood  hematopoietic  stem  cells  mobilized  by  granulocyte  colony-stimulating  factor  were
transplanted  intramuscularly  to  30  patients  with  peripheral  arterial  diseases  (IIb  stage  by
Pokrovsky).  Standart  tredmill  test,  anklebrachial  index  estimation  and ankle-brachial  index
restoration time estimation after loading were performed on 0, 3, 6, 12 and 60 months after
transplantation. Immunohistochemical study of injured gastrocnemius muscle biopsies taken
before  peripheral  blood  hematopoietic  stem cells  transplantation  and  3  months  after  the
procedure was performed. Peripheral blood hematopoietic stem cells transplantation increases
capillary density (22,4%, p = 0,0005). Anklebrachial index increased by 18,1% on month 6 after
transplantation without a tendency to change on month 12. 60 months after transplantation
initial  to  hematopoietic  stem cells  transplantation ankle-brachial  index rates were marked.
Painless walking distance was increasing at all times of observation progressively, on month 60
no walking distance limitation was marked by most patients. Ankle-brachial index restoring time
shows positive trend of the functional state of limb during the first year after transplantation, 60
months after transplantation it showed no «walking reserve» limitation in most patients. 5-years
survival was 79%, death causes were stroke, cardiac pathology (3 cases), lung cancer. So,
peripheral blood hematopoietic stem cells transplantation allows eliminating peripheral arterial
diseases symptoms and preserving limb in long-term period.  Autologous transplantation of
peripheral  blood hematopoietic stem cells  has no complications and is  safe for therapy of
patients with peripheral arterial diseases II stage. © Human stem cells institute, 2013.
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